Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Signaling Lymphocytic Activation Molecules (SLAM) family receptors are initially described in immune cells. These receptors recruit both activating and inhibitory SH2 domain containing proteins through their Immunoreceptor Tyrosine based Switch Motifs (ITSMs). Accumulating evidence suggest that the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Fouquet, Gregory, Marcq, Ingrid, Debuysscher, Véronique, Bayry, Jagadeesh, Rabbind Singh, Amrathlal, Bengrine, Abderrahmane, Nguyen-Khac, Eric, Naassila, Mickael, Bouhlal, Hicham
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5882332/
https://ncbi.nlm.nih.gov/pubmed/29662641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24575
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares